Group 1: Core Views - The article highlights the recent surge in A-share market, particularly the significant rise of Hengyun Chang, which saw a peak increase of over 320% on its debut, yielding nearly 150,000 yuan per share [1][6] - This week, two new stocks are available for subscription: Yisiwei and Aide Technology, with Yisiwei being a leader in automotive manufacturing machine vision equipment and Aide Technology focusing on orthopedic medical devices [1][4] Group 2: Yisiwei Overview - Yisiwei's offering price is set at 55.95 yuan per share, with a maximum subscription limit of 6,000 shares per account, requiring a market value of 60,000 yuan in the Shanghai market for full subscription [1] - The company has developed over ten products for various automotive manufacturing processes, achieving a market share of 22.5% in China's automotive machine vision sector by 2024, surpassing foreign competitors [2] - Yisiwei's revenue projections for 2022 to 2024 are 223 million yuan, 355 million yuan, and 392 million yuan, respectively, with net profits of 6.12 million yuan, 61.06 million yuan, and 85.64 million yuan [2] Group 3: Aide Technology Overview - Aide Technology's offering price is 7.67 yuan per share, with a maximum subscription limit of 1.3288 million shares [4] - The company specializes in orthopedic medical devices, focusing on a comprehensive range of products for spinal, trauma, and sports medicine, and has developed several core technologies [4] - Revenue forecasts for Aide Technology from 2022 to 2024 are 286 million yuan, 262 million yuan, and 275 million yuan, with net profits of 93 million yuan, 64 million yuan, and 67 million yuan [4]

Group 1: New Stock Offerings - Two new stocks are available for subscription on February 2, including Yisiwei on the Sci-Tech Innovation Board and Aide Technology on the Beijing Stock Exchange [2] - Aide Technology's total issuance, online issuance, and subscription limit rank first among new stocks on the Beijing Stock Exchange since 2026, with a subscription limit of 1.3288 million shares [2][3] - The total issuance of Aide Technology is 29.53 million shares, with 26.58 million shares available for online subscription [4] Group 2: Aide Technology Overview - Aide Technology is a leading company in the domestic medical device sector, focusing on orthopedic consumables, including spinal, trauma, and sports medicine products [4][6] - The company ranks third in the domestic market for spinal vertebral body augmentation systems and sixth for spinal implant medical devices [6] - Aide Technology's revenue for 2022 to 2025 is projected to be 286 million, 262 million, 275 million, and 149 million yuan, respectively, with net profits of approximately 93.28 million, 63.57 million, 67.13 million, and 38.15 million yuan [8][9] Group 3: Yisiwei Overview - Yisiwei is a leading company in the domestic machine vision sector, focusing on the development, production, and sales of machine vision equipment for automotive manufacturing [10][11] - The total issuance of Yisiwei is 25 million shares, with 6 million shares available for online subscription and a subscription limit of 600 shares [11] - Yisiwei's revenue for 2022 to 2025 is projected to be 223 million, 355 million, 392 million, and 125 million yuan, respectively, with net profits of approximately 6.12 million, 61.06 million, 85.64 million, and a loss of 509,910 yuan [13][14]

Core Viewpoint - Easy Vision (Hangzhou) Technology Co., Ltd. has received acceptance for its IPO application on the Shanghai Stock Exchange's Sci-Tech Innovation Board, aiming to raise 1.214 billion yuan [1] Company Overview - Easy Vision specializes in the research, production, and sales of machine vision equipment for automotive manufacturing, holding the largest market share in China and recognized as a key "little giant" enterprise [1] - The company has successfully broken the long-standing monopoly of foreign manufacturers in the machine vision sector, significantly reducing costs for domestic automotive manufacturers and promoting the digital transformation of the industry [1] Market Position - As of the end of 2024, Easy Vision's market share in China's automotive manufacturing machine vision products reached 22.5%, surpassing foreign competitors and becoming the only Chinese company in this field with annual revenues exceeding 100 million yuan [2][3] Product Development - Easy Vision has developed over ten products that are widely applied across six major manufacturing processes: stamping, welding, painting, assembly, battery, and die-casting, establishing a leading advantage in product variety and application coverage [2] Financial Performance - The company reported revenues of approximately 223 million yuan, 355 million yuan, and 392 million yuan for the years 2022, 2023, and 2024, respectively, with net profits of approximately 5.39 million yuan, 57.75 million yuan, and 84.33 million yuan during the same periods [3][4] - Key financial metrics for 2024 include total assets of 703.56 million yuan, equity attributable to shareholders of 477.47 million yuan, and a debt-to-asset ratio of 32.78% [4]